Long-Term Safety and Efficacy of Esketamine in Patients With Treatment-Resistant Depression: A Review of Interim Results From the SUSTAIN-3 Trial
Advertisement
Advertisement
Trending on AJMC
1
Cefdinir Nearly Doubles Outpatient Uncomplicated UTI Treatment Failure Compared With Cephalexin
2
Stronger Carer-Child Bonds Don’t Predict Later Mental Health
3
Five Ways AI Is Transforming Cancer Care—and Companies That Are Making It Happen
4
FDA to Remove Black Box Warnings From HRT, Debate Ensues
5
